Table: Kubota Pharmaceutical Holdings -2019 parent results
Feb 13 (Reuters)-
Kubota Pharmaceutical Holdings Co., Ltd.
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Dec 31, 2019 Dec 31, 2018 Dec 31, 2020 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Revenues 263 mln 259 mln
(+1.5 pct)
Operating loss 157 mln loss 410 mln
Recurring loss 166 mln loss 424 mln
Net 94 mln loss 342 mln
EPS 2.26 yen loss 8.81 yen
EPS Diluted 2.25 yen
Ann Div NIL NIL NIL
-Q2 Div NIL NIL NIL
-Q4 Div NIL NIL NIL
NOTE - Kubota Pharmaceutical Holdings Co., Ltd..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4596.T
Recent news on Kubota Pharmaceutical Holdings
See all newsTable: Kubota Pharmaceutical Holdings 6-MTH group results (IFRS)
Table: Kubota Pharmaceutical Holdings -Q1 group results (IFRS)
Brief: Kubota Vision Signs Supply & Licensing Agreement With Laboratoires Kôl
Table: Kubota Pharmaceutical Holdings -2025 parent results
Table: Kubota Pharmaceutical Holdings -2025 group results (IFRS)